LFG
ADPT icon

Larson Financial Group’s Adaptive Biotechnologies ADPT Stock Holding History

Larson Financial Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$902 Sell
65
-146
-69% -$2.33K ﹤0.01% 3189
2025
Q4 		$3.43K Buy
211
+141
+201% +$2.3K ﹤0.01% 2612
2025
Q3 		$1.05K Buy
+70
New +$853 ﹤0.01% 2908

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Larson Financial Group's ADPT Position: Q1 2026 in Review

Larson Financial Group reduced its Adaptive Biotechnologies (ADPT) stake by 69% in Q1 2026, selling an estimated $2.33K and leaving 65 shares worth $902. The position accounts for ﹤0.01% of the portfolio, ranked #3189.

Larson Financial Group first reported a position in ADPT in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.43K in Q4 2025. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Larson Financial Group held 65 shares of Adaptive Biotechnologies worth $902 as of Q1 2026.
  • Larson Financial Group sold 146 Adaptive Biotechnologies shares in Q1 2026, an estimated $2.33K.
  • Adaptive Biotechnologies made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #3189 holding.
  • Larson Financial Group first reported a position in Adaptive Biotechnologies in Q3 2025 and has held it in 3 quarters since.
  • Larson Financial Group's Adaptive Biotechnologies position peaked at $3.43K in Q4 2025.
  • 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.